Acarix AB is engaged in the provision of medical devices for monitoring Coronary Artery Disease. It develops and commercializes diagnostic tests based on its technology platform CADScor System. The company was founded by Peter Boman Samuelsen, Samuel Schmidt, Weimin Rong and Claus Bo Vöge Christensen in 2009 and is headquartered in Malmo, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company